Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-22-016912
Filing Date
2022-05-05
Accepted
2022-05-05 18:33:12
Documents
2
Period of Report
2022-05-05

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1617
2 EX-24 DOCUMENT attachment1.htm EX-24 3851
  Complete submission text file 0000899243-22-016912.txt   6816
Mailing Address 1800 - 510 WEST GEORGIA STREET VANCOUVER A1 BC V6B 0M3
Business Address 1800 - 510 WEST GEORGIA STREET VANCOUVER A1 BC V6B 0M3 908-541-5456
Bausch & Lomb Corp (Issuer) CIK: 0001860742 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
SIC: 3851 Ophthalmic Goods

Mailing Address C/O APPLIED GENETIC TECHNOLOGIES CORP. 14193 NW 119TH TERRACE, SUITE 10 ALACHUA FL 32615
Business Address
Hashad Yehia (Reporting) CIK: 0001877701 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41380 | Film No.: 22898205